Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating EpiBone-CMF for mandibular reconstruction is ongoing with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EpiBone-CMF (EpiBone-CMF)

Snippet

Sponsor: Epibone, Inc. | Conditions: Mandible Tumor, Mandibular Injuries | Phase 1, Phase 2 | Status: UNKNOWN